A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC

Clinical trial NCT00144989 · COMPLETED

Trial details

NCT number: NCT00144989
Sponsor: Haruhiko Fukuda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Small-Cell-Lung Cancer

Start date: 2002-09-01
Primary completion: 2011-09-01
Enrollment: 281

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.